During the past decade, Millard Fillmore Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Millard Fillmore Hospital" #1 sponsor was "University at Buffalo" with 3 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored, "CancerVax Corporation" with 2 trials sponsored and "State University of New York at Buffalo" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Millard Fillmore Hospital" #1 collaborator was "American Diabetes Association" with 2 trials as a collaborator, "Amylin Pharmaceuticals, LLC." with 1 trials as a collaborator, "Buffalo General Medical Center" with 1 trials as a collaborator, "Erie County Medical Center" with 1 trials as a collaborator and "Millard Fillmore Suburban Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Millard Fillmore Hospital" are "Stroke" (3 trials), "Carotid Stenosis" (2 trials), "Malignant Melanoma" (2 trials), "Type 2 Diabetes" (2 trials) and "Anemia" (1 trials). Many other conditions were trialed in "Millard Fillmore Hospital" in a lesser frequency.

Most popular intervention types in "Millard Fillmore Hospital" are "Drug" (8 trials), "Device" (5 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (3 trials), "CancerVax vaccine (CANVAXIN)" (2 trials), "Acetaminophen" (1 trials), "Carotid Stent Implantation" (1 trials) and "Carotid artery endarterectomy (surgical)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Millard Fillmore Hospital" are 14 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Millard Fillmore Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Millard Fillmore Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Millard Fillmore Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".